124 related articles for article (PubMed ID: 38553373)
1. Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer.
Wen W; Li Y; Cao X; Li Y; Liu Z; Tang Z; Xie L; He R
Clin Breast Cancer; 2024 Mar; ():. PubMed ID: 38553373
[TBL] [Abstract][Full Text] [Related]
2. Identifying the role of NUDCD1 in human tumors from clinical and molecular mechanisms: a study based on comprehensive bioinformatics and experimental validation.
Han B; He J; Chen Q; Yuan M; Zeng X; Li Y; Zeng Y; He M; Feng D; Ma D
Aging (Albany NY); 2023 Jun; 15(12):5611-5649. PubMed ID: 37338527
[TBL] [Abstract][Full Text] [Related]
3. miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification.
Han B; Xu K; Feng D; Bai Y; Liu Y; Zhang Y; Zhou L
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1903-1918. PubMed ID: 35476233
[TBL] [Abstract][Full Text] [Related]
4. NudCD1 affects renal cell carcinoma through regulating LIS1/Dynein signaling pathway.
He H; Dai J; Wang X; Qian X; Zhao J; Wang H; Xu D
Am J Transl Res; 2018; 10(2):519-524. PubMed ID: 29511446
[TBL] [Abstract][Full Text] [Related]
5. NudCD1 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells through the Activation of IGF1R-ERK1/2.
He B; Xia S; Zhang Z
Pathobiology; 2020; 87(4):244-253. PubMed ID: 32634806
[TBL] [Abstract][Full Text] [Related]
6. NudCD1 as a prognostic marker in colorectal cancer and its role in the upregulation of cellular spindle assembly checkpoint genes and LIS1 pathways.
Feng WM; Gong H; Wang YC; Wang Y; Xue T; Zhang T; Cui G
BMC Cancer; 2022 Sep; 22(1):981. PubMed ID: 36104662
[TBL] [Abstract][Full Text] [Related]
7. HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer.
Zhu M; Liu N; Lin J; Wang J; Lai H; Liu Y
Oncol Lett; 2023 Jan; 25(1):33. PubMed ID: 36589669
[TBL] [Abstract][Full Text] [Related]
8. NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer.
Han B; Zhang YY; Xu K; Bai Y; Wan LH; Miao SK; Zhang KX; Zhang HW; Liu Y; Zhou LM
Am J Cancer Res; 2018; 8(5):810-823. PubMed ID: 29888104
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway.
Wang G; Zhang X; Zhou Z; Song C; Jin W; Zhang H; Wu W; Yi Y; Cui H; Zhang P; Liu X; Xu W; Shen X; Shen W; Wang X
Discov Oncol; 2023 Jan; 14(1):4. PubMed ID: 36631680
[TBL] [Abstract][Full Text] [Related]
10. LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer.
Zhang Z; Gu M; He G; Yu X; Yang J; Wu X; Zhang X; Lu K; Qian F; Shi X; Xu J; Zhuang M; Liu X; Zhu Y
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345110
[TBL] [Abstract][Full Text] [Related]
11. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
Liao H; Zhang L; Lu S; Li W; Dong W
Front Genet; 2022; 13():848926. PubMed ID: 35812733
[No Abstract] [Full Text] [Related]
12. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zhu J; Lv J; Chen J; Zhang X; Ji Y
Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
[No Abstract] [Full Text] [Related]
13. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
14. PI3K/AKT/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients.
Geng Y; Geng Y; Liu X; Chai Q; Li X; Ren T; Shang Q
Front Oncol; 2023; 13():1167930. PubMed ID: 37152048
[TBL] [Abstract][Full Text] [Related]
15. NUDCD1 knockdown inhibits the proliferation, migration, and invasion of pancreatic cancer via the EMT process.
Shi C; Weng M; Zhu H; Guo Y; Xu D; Jin H; Wei B; Cao Z
Aging (Albany NY); 2021 Jul; 13(14):18298-18309. PubMed ID: 34325402
[TBL] [Abstract][Full Text] [Related]
16. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
17. PI3K/AKT/mTOR signaling pathway modulation by circular RNAs in breast cancer progression.
Karami Fath M; Akhavan Masouleh R; Afifi N; Loghmani S; Tamimi P; Fazeli A; Mousavian SA; Falsafi MM; Barati G
Pathol Res Pract; 2023 Jan; 241():154279. PubMed ID: 36584499
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma.
Fan D; Liu Q; Wu F; Liu N; Qu H; Yuan Y; Li Y; Gao H; Ge J; Xu Y; Wang H; Liu Q; Zhao Z
PeerJ; 2020; 8():e9261. PubMed ID: 32547875
[TBL] [Abstract][Full Text] [Related]
19. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.
Wei Z; Xia K; Zheng D; Gong C; Guo W
Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274
[TBL] [Abstract][Full Text] [Related]
20. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
